Iqvia Holdings IQV
NYSE IQV
$271.75 +6.89 (+2.60%)
At close: Nov 6, 2026 · 4:00 PM EST

Iqvia Holdings (IQV) Gains from Sales and Divestitures (2013 - 2014)

Updated

Analysis

Iqvia Holdings (IQV) Gains from Sales and Divestitures (2013 - 2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.71 Bn 35.96 Bn 1.50 Bn
2 Medpace Holdings 18.26 Bn 15.91 Bn 223.89 Mn
3 Charles River Laboratories International 16.16 Bn 15.36 Bn 357.87 Mn
4 Icon 16.06 Bn 12.83 Bn 491.83 Mn
5 Fortrea Holdings 2.10 Bn 1.39 Bn 139.50 Mn
6 Ginkgo Bioworks Holdings 699.49 Mn -62.59 Mn 18.44 Mn
7 Evotec SE 601.99 Mn -1.16 Bn -
8 Champions Oncology 66.71 Mn 41.80 Mn 7.70 Mn
9 MindWalk Holdings 48.93 Mn 12.59 Mn 1.61 Mn
10 Natural Alternatives International 6.57 Mn -21.51 Mn 1.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2014 77,000.00
Mar 31, 2014 181,000.00
Jun 30, 2013 262,000.00
Mar 31, 2013 296,000.00
API Access

Iqvia Holdings Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=IQV&period=max&api_key=YOUR_API_KEY